Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment

An increasing percentage of people have or are at risk to develop non-alcoholic fatty liver disease (NAFLD) worldwide. NAFLD comprises different stadia going from isolated steatosis to non-alcoholic steatohepatitis (NASH). NASH is a chronic state of liver inflammation that leads to the transformatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Med (Lausanne)
Autors principals: Heyens, Leen J. M., Busschots, Dana, Koek, Ger H., Robaeys, Geert, Francque, Sven
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021
Matèries:
Medicine
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8079659/
https://ncbi.nlm.nih.gov/pubmed/33937277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2021.615978
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars